Learn, Analyse & Invest
only with
only with
+91
Download Orca
Shukra Pharmaceuticals Ltd.
Shukra Pharma
₹ 0.00
0.00 (0.00)%
NSE
BSE
Healthcare
Small-cap - With a market cap of ₹13.96 Cr.
| EX-Date | Purpose |
|---|---|
| 29 06 2021 | Quarterly Results & Inter alia, to consider To appoint CS Rupal Patel, Practicing Company Secretary as Secretarial Auditor of the Company for the F.Y. 2020-21. 3. Any other business with the permission of the Chair. |
| 14 08 2021 | Quarterly Results |
| 30 10 2021 | Quarterly Results |
| 12 02 2022 | Quarterly Results & Inter alia, to consider and approve 1. To consider, adopt and approve Un-audited Financial Results for the quarter ended on 31st December, 2021. 2. Acceptance of resignation of Mr. Nileshkumar Patel (DIN: 08316887) as Director of the company. 3. Appointment of M/s Shah Sanghvi and Associates as internal auditor of the company. 4. Any other business with the permission of chair. |
| 26 03 2022 | i. Review the performance of Non-Independent Directors and the Board as whole. ii. Review performance of the Chairperson of the Company. iii. Access the Quantity, Quality and timeliness of flow of information. iv. Any other business with the permission of Chair. |
| 28 05 2022 | Audited Results Inter alia, To appoint CS Rupal Patel, Practicing Company Secretary as Secretarial Auditor of the Company for the F.Y. 2021-22. |
| 06 08 2022 | Quarterly Results |
| 25 08 2022 | Right Issue of Equity Shares & Inter alia, to consider and approve : 1. To consider in principle, the issue of equity shares of face value of Rs. 10/- each on a rights basis (?Rights Issue?) to the shareholders of the Company. 2. To appoint intermediaries for the purpose of Right Issue of equity shares in accordance with the SEBI Regulations. 3. To consider and appoint Mr. Rai Kavoorguthu Konark (DIN- 08447991) as an additional independent director of the Company. 4. Any other business with the permission of chair. |
| 01 09 2022 | Inter alia, to consider and approve : 1. To consider and approve draft of Director?s Report and Secretarial Audit Report for the year ended March 31, 2022. 2. To fix day, date, time and venue for Annual General meeting. 3. To decide on the dates for closure of the Register of Members and Share Transfer Register for the purpose of Annual Book Closure. 4. To consider and approve draft of notice for Annual General Meeting. 5. To appoint Scrutinizer for the process of Remote E-voting as well as voting at the AGM. 6. To appoint internal auditor of the company for Financial Year 2022-23. 7. Any other business with the permission of chair. |
| 12 11 2022 | Quarterly Results |
| 18 01 2023 | Inter alia, to consider and approve :- 1) To fix the record date for the rights issue; 2) To fix the right entitlement ratio and the price for the equity shares of the Rights Issue; 3) To specify the ISIN for Rights Entitlements; 4) To fix the term of payment of issue; 5) To fix the issue opening and closing date; and 6) other matters and terms and conditions incidental or connected therewith. |
| 14 02 2023 | Quarterly Results |
| 05 04 2023 | Inter alia, to consider and approve :- 1) Proposal of making of First Call on 93,94,050 (Ninety-Three Lakh Ninety-Four Thousand and Fifty Shares) partly paid-up equity shares having face value of Rs. 10/- each (Rs. 5/- paid on application on which Rs. 2.5/- towards face value and Rs. 2.5/- towards premium amount) issued by the Company on a rights basis pursuant to Letter of Offer dated February 01, 2023 and other matters connected therewith. 2) Fixing of the record date for ascertaining eligible shareholders to whom call letters shall be dispatched. 3) Any other matter with the permission of the chair. |
| 29 05 2023 | Final Dividend & Audited Results |
| 28 06 2023 | Inter alia, to consider and approve :- 1) Proposal for sending of a Final Demand cum Forfeiture Notice - Reminder 1 for payment of First Call Money of Rs. 7.00 per partly paid-up Equity Share (comprising Rs. 3.5 towards face value and Rs. 3.50 towards share premium) per partly paid-up equity share, as First Call Money (Reminder Notice) to the holders of such partly paid-up Equity Shares on which the First Call Money remains un-paid. 2) Proposal of making of Second and Final Call on 93,94,050 (Ninety-Three Lakh Ninety-Four Thousand and Fifty Shares) partly paid-up equity shares having face value of Rs. 10/- each on which Rs. 12/- paid on application and first call (Rs. 6/- towards face value and Rs. 6/- towards premium amount), issued by the Company on a rights basis pursuant to Letter of Offer dated February 01, 2023 and other matters connected therewith. 3) Fixing of the record date for ascertaining eligible shareholders to whom call letters shall be dispatched. 4) Any other matter with the permission of the chair. |
| 12 08 2023 | Quarterly Results |
| 08 11 2023 | Quarterly Results |
| 12 02 2024 | Quarterly Results |
| 29 02 2024 | Increase in Authorised Capital & Bonus issue Inter alia, to consider and approve :- 1. To consider and approve the proposal for issuance of fully paid up bonus equity shares to the members of the Company subject to necessary approval; 2. To consider and approve the proposal of increase in the authorized share capital of the Company and subsequent alteration to the Memorandum of Association of the Company. if needed, subject to necessary approval; 3. To consider and finalize the matters to be included in Notice of EGM/Postal Ballot including day, Date, Place & Time, if required; |
| 28 09 2024 | Right Issue of Equity Shares |
| 14 11 2024 | Quarterly Results |
| 29 01 2025 | Stock Split |
| 14 02 2025 | Quarterly Results |
| 29 05 2025 | Audited Results |
| 04 06 2025 | Final Dividend |
| 13 08 2025 | Quarterly Results |
| 03 10 2025 | Inter alia to consider and approve the following: - 1. Preferential Issue of warrants as per Chapter V and in accordance with Securities arid Exchange Board of India (Issue of capital and Disclosure requirements) Regulations 2018 to Promoters subject to approval of shareholders and such other approvals as may be required under applicable laws; 2. To declare and fix relevant date for the Pproposed preferential issue. 3. fix day, date, time and venue for Extra-ordinary General meeting (EGM); 4. Appointment of scrutinizer for the process of Remote E-voting as well as voting at the EGM; 5. Any other business with the permission of Chairman, |
| 13 11 2025 | Quarterly Results |
| 04 02 2026 | Quarterly Results (Revised) |
| 16 03 2026 | Inter alia, to transact the following business: 1) To review the performance of Non-Independent Directors and the Board as a whole. 2) To Review the performance of the Chairman of the Company. 3) To access the Quantity, Quality and timeliness of flow of information. 4) Any other business with the permission of the chair. |
News
